NC
TXMD icon

Nexthera Capital’s TherapeuticsMD TXMD Stock Holding History

Nexthera Capital’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-26,142
Closed -$8.57M – 43
2018
Q3 		$8.57M Buy
+26,142
New +$8.01M 1.64% 20
2018
Q1 		– Sell
-10,567
Closed -$3.19M – 52
2017
Q4 		$3.19M Buy
+10,567
New +$2.94M 0.59% 34

Other funds holding TXMD

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Nexthera Capital's TXMD Position: Q4 2018 in Review

Nexthera Capital sold out of TherapeuticsMD (TXMD) in Q4 2018, closing a stake of 26,142 shares — an estimated $8.57M sold.

Nexthera Capital first reported a position in TXMD in Q4 2017 and held it in 2 quarters. The position peaked at $8.57M in Q3 2018. 140 funds tracked by Wall St. Rank hold TXMD as of Q4 2018.

  • Nexthera Capital reported no remaining TherapeuticsMD position as of Q4 2018 after selling out during the quarter.
  • Nexthera Capital sold 26,142 TherapeuticsMD shares in Q4 2018, an estimated $8.57M.
  • Nexthera Capital first reported a position in TherapeuticsMD in Q4 2017 and held it in 2 quarters.
  • Nexthera Capital's TherapeuticsMD position peaked at $8.57M in Q3 2018.
  • 140 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2018.

Based on Nexthera Capital's 13F filing for Q4 2018, filed 14 Feb 2019.